OncoSec presented today in Boston, they will be presenting next week at Marcum in NYC, and then going straight to ASCO to attend. They are making all the right moves to get the word out.
According to the Milestone Timeline they are projecting to release data in July, which will coincide with EADO. Then again, they gave us some early data the end of March,which was not listed on the timeline and was probably done to make a direct comparison to the press release from Amgen. So, even with the timeline listing mid-July, one never knows.
ONCS has been receiving some great press and people are taking notice. As we follow this rising trend, one can certainly try to time the ups and downs to pull some profit or sell and buy back to increase their shares, but that is VERY risky with the potential this stock has to take off. Myself, I am simply waiting and watching and enjoying the watching as the pps rises and the volume increases. If I had some extra cash to invest I would be buying.
A recent contact with ONCS gave assurance that NeoPulse is still in discussion regarding partnership. As conjecture, this continues to look like whomever the discussion is with, is waiting on ImmunoPulse data to try and take a BIG piece. Whether that be as a large partner or an outright buyout, we will have to wait and see.
Either way, ONCS is looking VERY STRONG, is receiving many STRONG BUY ratings, and I am very happy to have gotten in early.